Similar articles for PMID: 17869078

Year	Number of Results
1989	2
1991	3
1992	1
1993	1
1994	1
1995	4
1996	1
1997	3
1998	4
1999	5
2000	2
2001	3
2002	7
2003	7
2004	10
2005	31
2006	28
2007	41
2008	18
2009	20
2010	19
2011	12
2012	15
2013	6
2014	4
2015	10
2016	10
2017	9
2018	15
2019	12
2020	13
2021	6
2022	9
2023	1
2024	0

1

The two faces of the 15-lipoxygenase in atherosclerosis.

Wittwer J, Hersberger M. Wittwer J, et al. Prostaglandins Leukot Essent Fatty Acids. 2007 Aug;77(2):67-77. doi: 10.1016/j.plefa.2007.08.001. Epub 2007 Sep 14. Prostaglandins Leukot Essent Fatty Acids. 2007. PMID: 17869078 Review.

2

Inflammation and immune regulation by 12/15-lipoxygenases.

Kühn H, O'Donnell VB. Kühn H, et al. Prog Lipid Res. 2006 Jul;45(4):334-56. doi: 10.1016/j.plipres.2006.02.003. Epub 2006 Mar 31. Prog Lipid Res. 2006. PMID: 16678271 Review.

3

The role of lipoxygenase-isoforms in atherogenesis.

Kühn H, Römisch I, Belkner J. Kühn H, et al. Mol Nutr Food Res. 2005 Nov;49(11):1014-29. doi: 10.1002/mnfr.200500131. Mol Nutr Food Res. 2005. PMID: 16270276

4

Lipoxins and new lipid mediators in the resolution of inflammation.

Schwab JM, Serhan CN. Schwab JM, et al. Curr Opin Pharmacol. 2006 Aug;6(4):414-20. doi: 10.1016/j.coph.2006.02.006. Epub 2006 Jun 5. Curr Opin Pharmacol. 2006. PMID: 16750421 Review.

5

5-LOX, 12-LOX and 15-LOX in immature forms of human leukemic blasts.

Vincent C, Fiancette R, Donnard M, Bordessoule D, Turlure P, Trimoreau F, Denizot Y. Vincent C, et al. Leuk Res. 2008 Nov;32(11):1756-62. doi: 10.1016/j.leukres.2008.05.005. Epub 2008 Jun 18. Leuk Res. 2008. PMID: 18561999

6

12/15 Lipoxygenase regulation of colorectal tumorigenesis is determined by the relative tumor levels of its metabolite 12-HETE and 13-HODE in animal models.

Chang J, Jiang L, Wang Y, Yao B, Yang S, Zhang B, Zhang MZ. Chang J, et al. Oncotarget. 2015 Feb 20;6(5):2879-88. doi: 10.18632/oncotarget.2994. Oncotarget. 2015. PMID: 25576922 Free PMC article.

7

Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins.

Hersberger M. Hersberger M. Clin Chem Lab Med. 2010 Aug;48(8):1063-73. doi: 10.1515/CCLM.2010.212. Clin Chem Lab Med. 2010. PMID: 20441482 Free article. Review.

8

Lipid inflammatory mediators in diabetic vascular disease.

Natarajan R, Nadler JL. Natarajan R, et al. Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1542-8. doi: 10.1161/01.ATV.0000133606.69732.4c. Epub 2004 May 27. Arterioscler Thromb Vasc Biol. 2004. PMID: 15166011 Review.

9

Interferon-gamma and atherosclerosis: pro- or anti-atherogenic?

Harvey EJ, Ramji DP. Harvey EJ, et al. Cardiovasc Res. 2005 Jul 1;67(1):11-20. doi: 10.1016/j.cardiores.2005.04.019. Cardiovasc Res. 2005. PMID: 15907820 Review.

10

Lipoxygenase-mediated pro-radical effect of melatonin via stimulation of arachidonic acid metabolism.

Radogna F, Sestili P, Martinelli C, Paolillo M, Paternoster L, Albertini MC, Accorsi A, Gualandi G, Ghibelli L. Radogna F, et al. Toxicol Appl Pharmacol. 2009 Jul 15;238(2):170-7. doi: 10.1016/j.taap.2009.05.011. Epub 2009 May 19. Toxicol Appl Pharmacol. 2009. PMID: 19460395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

299 results

Results by year